InsidersTradesSigma
Explore the detailed record of transactions filed by Dudley Robert Michael, Chief Executive Officer. Director active across 1 companies, notably Transcode Therapeutics, Inc.. Aggregated, 1 reports have been published. Total volume traded: €48k. The latest transaction was filed on 27 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Robert Michael Dudley is the Chief Executive Officer of Transcode Therapeutics, Inc. He oversees the company's operations and is responsible for implementing the development strategy. His expertise in the biopharmaceutical field enables him to lead innovative projects and promote research and development.